K.C. Pharmaceuticals was flagged by the FDA in 2023 for failing to ensure its eye drops were made in sterile conditions.
The company's current massive recall suggests it ignored those recommendations.
https://theconversation.com/massive-eye-drop-recall-reflects-ongoing-issues-with-manufacturing-and-fda-inspection-279971
The Conversation U.S.
npub1gp…q88e5
2026-04-09 10:30:01 UTC
Author Public Key
npub1gpefz2ehal9k2huay0kqawxapywweegvz968h9l33yay4wzzkrcspq88e5Published at
2026-04-09 10:30:01 UTCEvent JSON
{
"id": "72e2320ef53e4ed1f39266e025926584baceddaecd2591ef736522cc20f1f6a9",
"pubkey": "4072912b37efcb655f9d23ec0eb8dd091cece50c11747b97f1893a4ab842b0f1",
"created_at": 1775730601,
"kind": 1,
"tags": [
[
"proxy",
"https://newsie.social/@TheConversationUS/116374280729991892",
"web"
],
[
"proxy",
"https://newsie.social/users/TheConversationUS/statuses/116374280729991892",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://newsie.social/users/TheConversationUS/statuses/116374280729991892",
"pink.momostr"
],
[
"-"
]
],
"content": "K.C. Pharmaceuticals was flagged by the FDA in 2023 for failing to ensure its eye drops were made in sterile conditions.\n\nThe company's current massive recall suggests it ignored those recommendations.\n\nhttps://theconversation.com/massive-eye-drop-recall-reflects-ongoing-issues-with-manufacturing-and-fda-inspection-279971",
"sig": "5f9a5733caf7f454f372fb7c20fe49efd1914970c5f181d85f3447312eda8c714bd393dc17c8fa0dabf47fb8c52a71e8a2150b9d58fff619e26e1aca7ebc2eec"
}